Lu M - Search Results

1

A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.

Yuan L, Chen L, Qian K, Wang G, Lu M, Qian G, Cao X, Jiang W, Xiao Y, Wang X. Yuan L, et al. Among authors: lu m. Oncol Rep. 2018 Feb;39(2):525-536. doi: 10.3892/or.2017.6132. Epub 2017 Dec 4. Oncol Rep. 2018. PMID: 29207195 Free PMC article.

2

Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.

Yuan L, Zeng G, Chen L, Wang G, Wang X, Cao X, Lu M, Liu X, Qian G, Xiao Y, Wang X. Yuan L, et al. Among authors: lu m. Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018. Int J Biol Sci. 2018. PMID: 29559845 Free PMC article.

3

CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α.

Lu M, Ge Q, Wang G, Luo Y, Wang X, Jiang W, Liu X, Wu CL, Xiao Y, Wang X. Lu M, et al. Cell Death Dis. 2018 Oct 12;9(10):1046. doi: 10.1038/s41419-018-1109-5. Cell Death Dis. 2018. PMID: 30315244 Free PMC article.

4

miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.

Ge Q, Lu M, Ju L, Qian K, Wang G, Wu CL, Liu X, Xiao Y, Wang X. Ge Q, et al. Among authors: lu m. Int J Cancer. 2019 Jun 15;144(12):3043-3055. doi: 10.1002/ijc.32036. Epub 2019 Jan 12. Int J Cancer. 2019. PMID: 30511377

5

Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis.

Tang J, Lu M, Cui Q, Zhang D, Kong D, Liao X, Ren J, Gong Y, Wu G. Tang J, et al. Among authors: lu m. Front Oncol. 2019 Apr 24;9:310. doi: 10.3389/fonc.2019.00310. eCollection 2019. Front Oncol. 2019. PMID: 31106147 Free PMC article.

6

Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients.

Lu M, Chen S, Zhou Q, Wang L, Peng T, Wang G. Lu M, et al. Medicine (Baltimore). 2019 Jul;98(28):e16426. doi: 10.1097/MD.0000000000016426. Medicine (Baltimore). 2019. PMID: 31305463 Free PMC article.

7

Re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4.

Lu M, Zhang Y, Xiao Y. Lu M, et al. Eur Urol. 2019 Nov;76(5):e135-e136. doi: 10.1016/j.eururo.2019.07.044. Epub 2019 Aug 14. Eur Urol. 2019. PMID: 31420251 No abstract available.

8

EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer.

Zhou Q, Chen S, Lu M, Luo Y, Wang G, Xiao Y, Ju L, Wang X. Zhou Q, et al. Among authors: lu m. Int J Biol Sci. 2019 Aug 8;15(10):2139-2155. doi: 10.7150/ijbs.35541. eCollection 2019. Int J Biol Sci. 2019. PMID: 31592144 Free PMC article.

9

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma.

Chen S, Lu M, Peng T, Wang Y, Liu X, Xiao Y, Wang X. Chen S, et al. Among authors: lu m. J Cancer. 2019 Oct 11;10(24):5891-5902. doi: 10.7150/jca.35866. eCollection 2019. J Cancer. 2019. PMID: 31762799 Free PMC article.

10

Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.

Chen S, Zhou Q, Guo Z, Wang Y, Wang L, Liu X, Lu M, Ju L, Xiao Y, Wang X. Chen S, et al. Among authors: lu m. J Cell Mol Med. 2020 Jan;24(2):1804-1821. doi: 10.1111/jcmm.14878. Epub 2019 Dec 10. J Cell Mol Med. 2020. PMID: 31821699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,398 results

Search Page

Filters